Concepedia

Recommendations for the diagnosis and treatment of patients with polycythaemia vera

Antónia Hatalova, Mirjana Gotić, Miroslav Penka, M Hrubisko, Rajko Kušec, Miklós Egyed, Martin Grießhammer, Maria Podolak‐Dawidziak, Andrzej Hellmann, Sergiy Klymenko,

European Journal Of Haematology · 2018 · 13 citations · 56 references

DOI

Abstract

Greater understanding of PV is serving as a platform for new therapy development and treatment response predictors.

References

56

A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders

Róbert Královics, Francesco Passamonti, Andreas Buser et al. · New England Journal of Medicine · 2005 · 3.4K citations · Full text

Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

Raffaele Landolfi, Roberto Marchioli, Jack Kutti et al. · New England Journal of Medicine · 2004 · 986 citations · Full text

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Ayalew Tefferi, Jüergen Thiele, Attilio Orazi et al. · Blood · 2007 · 857 citations · Full text

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer et al. · New England Journal of Medicine · 2015 · 851 citations

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård et al. · Journal of Clinical Oncology · 2011 · 825 citations · Full text

, , +16